Rize Oncology Inc (RIZE)

CSE
Currency in CAD
0.12
+0.09(+300.00%)
Delayed Data·
RIZE Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
RIZE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.120.12
52 wk Range
0.020.15
Key Statistics
Edit
Bid/Ask
0.02 / 0.03
Prev. Close
0.03
Open
0.12
Day's Range
0.12-0.12
52 wk Range
0.02-0.15
Volume
2K
Average Volume (3m)
14.72K
1-Year Change
118.18%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
RIZE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory
No news in this category
Looks like there are no results in this news category

Rize Oncology Inc Company Profile

Rize Oncology Inc. engages in the development of oncology therapeutics. It develops STS-201, a small-molecule drug for the treatment of soft tissue sarcoma. The company was formerly known as GeneTether Therapeutics Inc. and changed its name to Rize Oncology Inc. in January 2025. Rize Oncology Inc. was founded in 2018 and is based in Kelowna, Canada.

0
Market
Canada

Compare RIZE to Peers and Sector

Metrics to compare
RIZE
Peers
Sector
Relationship
P/E Ratio
−3.0x−2.1x−0.5x
PEG Ratio
−2.87−0.050.00
Price/Book
1.5x0.3x2.6x
Price / LTM Sales
-1.9x3.0x
Upside (Analyst Target)
-136.7%52.7%
Fair Value Upside
Unlock23.4%7.6%Unlock

Earnings

Latest Release
Apr 16, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Rize Oncology (RIZE) Stock Price Today?

The Rize Oncology stock price today is 0.12

What Stock Exchange Does Rize Oncology Trade On?

Rize Oncology is listed and trades on the Canadian Securities Exchange stock exchange.

What Is the Stock Symbol for Rize Oncology?

The stock symbol for Rize Oncology is "RIZE."

What Is the Rize Oncology Market Cap?

As of today, Rize Oncology market cap is 9.09M.

What Is Rize Oncology's Earnings Per Share (TTM)?

The Rize Oncology EPS (TTM) is -0.01.

From a Technical Analysis Perspective, Is RIZE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Rize Oncology Stock Split?

Rize Oncology has split 0 times.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.